Shares of KindlyMD, Inc. (NASDAQ:NAKA – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $0.75.
A number of research analysts recently issued reports on NAKA shares. Weiss Ratings restated a “sell (e+)” rating on shares of KindlyMD in a research note on Friday, March 27th. Maxim Group dropped their price target on KindlyMD from $1.50 to $0.75 and set a “buy” rating on the stock in a research note on Monday, April 6th. B. Riley Financial dropped their price target on KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a research note on Monday, February 23rd. Finally, TD Cowen started coverage on KindlyMD in a research note on Friday, April 10th. They set a “buy” rating and a $1.00 price target on the stock.
Get Our Latest Stock Analysis on KindlyMD
KindlyMD Stock Performance
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in NAKA. Sagespring Wealth Partners LLC purchased a new position in KindlyMD during the 4th quarter worth approximately $28,000. SG Americas Securities LLC purchased a new position in KindlyMD during the 4th quarter worth approximately $61,000. Virtu Financial LLC purchased a new position in KindlyMD during the 4th quarter worth approximately $151,000. J. Derek Lewis & Associates Inc. purchased a new position in KindlyMD during the 4th quarter worth approximately $167,000. Finally, Truist Financial Corp purchased a new position in KindlyMD during the 4th quarter worth approximately $176,000.
About KindlyMD
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.
Further Reading
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
